London, September 10
British start-up firm iAbra mentioned it had developed a 20-second saliva COVID-19 check which had 99.8% sensitivity and 96.7% specificity.
Trials of the “Virolens” check have taken place at Heathrow Airport, the corporate, which was based in 2010, mentioned.
“Our system allows simple, high speed, reliable and low-cost testing in dynamic environments,” Greg Compton, CEO of iAbra, added in an announcement. Reuters